FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Therivas Pancreatic Cancer Drug Hits Endpoints

[ Price : $8.95]

Theriva Biologics reports positive Phase 2b VIRAGE topline results for its VCN-01 when added to standard of care chemotherapy to t...

Moderna Flu/Covid Vaccine Beats Comparators: Study

[ Price : $8.95]

A Moderna Phase 3 study says its combination mRNA flu and Covid-19 vaccine achieved a greater immune response than comparator stan...

Omeros BLA Resubmission for Narsoplimab

[ Price : $8.95]

FDA accepts for review an Omeros BLA resubmission for narsoplimab for treating hematopoietic stem cell transplant-associated throm...

Bill Would Create FDA Inspector General

[ Price : $8.95]

Sen. Eric Schmitt introduces legislation to create an inspector general for FDA and two other public health agencies.

Oncologic Panel to Review 4 Cancer Submissions

[ Price : $8.95]

FDA announces a 5/20-21 Oncologic Drugs Advisory Committee meeting to review and vote on four cancer drug submissions.

FDA Panel to Mull Covid Vaccine Strain Selection

[ Price : $8.95]

FDA announces a 5/22 Vaccines and Related Biological Products Advisory Committee meeting to discuss and make recommendations on th...

More Unannounced Foreign Inspections Coming

[ Price : $8.95]

FDA says it is expanding the use of unannounced inspections of foreign medical product and food manufacturing facilities.

FDA Ordered to Speed U.S. Drug Manufacturing

[ Price : $8.95]

President Trump signs an Executive Order requiring FDA to take steps to increase domestic drug manufacturing.

Vinay Prasad Tapped as New CBER Director

[ Price : $8.95]

FDA appoints University of California, San Francisco professor Vinay Prasad to serve as CBERs new director, replacing Peter Marks,...

BIMO Inspection e-Submission Requirements Outlined

[ Price : $8.95]

An FDA Webinar discusses drug study information in NDAs/BLAs that will need to be electronically submitted in a certain format to ...